Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
m-Cresol (3-methylphenol) is an organic compound and one of the three isomeric cresols. It appears as a colorless to light yellow viscous liquid with a characteristic tar-like odor. m-Cresol is primarily used as an intermediate in the production of chemicals such as pesticides (e.g., fenitrothion), synthetic vitamin E, antiseptics (e.g., amylmetacresol), and resins. In pharmaceuticals, it serves as an antimicrobial preservative in multi-dose peptide and protein formulations (notably insulin) and has topical dental antiseptic properties. Mechanistically, it acts as an antimicrobial agent by disrupting microbial cell membranes; at higher concentrations it can inhibit platelet aggregation via cyclooxygenase-1 inhibition[1][4][8]. It is also used industrially as a solvent for polymers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on m-Cresol.